Journal of Chemical and Pharmaceutical Research (ISSN : 0975-7384)

header
Reach Us reach to JOCPR whatsapp-JOCPR +44 1625708989
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Original Articles: 2010 Vol: 2 Issue: 3

Formulation of immediate release dosage form of Ranitidine HCl tabletsusing HPMC and starch acetate film former

Abstract

The “objective” of this project work was to formulate a stable safe and effective film coated immediate release solid dosage form of “Ranitidine HCl” that spontaneously release the drug when expose into GIT for producing anti-ulcer effec t. One of the major steps in formulation development activity is the development of “Film co ating formulation and process” using hydroxy propyl methyl cellulose (HPMC-2208) and sta rch acetate film former. More particularly the dosage form is adapted for water soluble drugs and comprises a plurality of coated particles, wherein each has multiple layers about a core conta ining a drug active. The development of a tablet containing a moisture sensitive drug is subj ect to those high temperatures and high humidity during the film coating process. HPMC-2208 and starch acetate (SA) (50 : 50), used as an excipient for immediate release of drug, on the release profiles and bioavailability of the poorly water-soluble Ranitidine(RT) from a tablet. Although RT is a poorly water-soluble drug, it was rapidly dissolved from the RT-HPMC-SA and du e to the improvement of its dissolution rate in the presence of HPMC and starch acetate. Analysis of parameters for diam eter, thickness, average weight, hardness and uniformity of weight s atisfies the limit of the specification for the Nansri Saha Ghosh et al J. Chem. Pharm. Res., 2010, 2(3):147-157 148 immediate release formulation. Dissolution studies showed that all the three baches prepared having 98.9, 99.8 & 99.9 % dissolution for the Batc h I, Batch II & Batch III respectively. The “scope” of this dissertation work is to maintain th e solubility, dissolution and disintegration rate to probably improve oral bioavailability of the dru g for producing process therapeutic effect.